The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...

Hemophilia is an inherited genetic condition. There is no cure for hemophilia, but treatment could help you manage symptoms and prevent future health complications. The symptoms of hemophilia may ...

Over the last three years, the FDA has approved six new hemophilia drugs, including three gene therapies. | Over the last ...

Alhemo prophylaxis is linked to better quality of life and a lower treatment burden for hemophilia patients without ...

The X chromosome is larger and commands more regulatory functions throughout the brain and body. While diseases such as color-blindness and hemophilia have long been understood to be X-linked ...

Hemophilia is a genetic bleeding disorder that prevents blood from properly clotting. Severe bleeding from minor injuries or surgery can occur. Low levels or the absence of some proteins ...

About 30% of people hospitalized due to acquired hemophilia have a bleeding event, while 17% have a blood clot-related ...

Investing.com -- The US Food and Drug Administration (FDA) has approved Sanofi (NASDAQ: SNY )’s treatment for hemophilia, Qfitlia (fitusiran), which can be administered as infrequently as once every ...

Identification of carrier females is crucial for genetic counselling in hemophilia B; the problem is that hematological data are equivocal unless the factor IX level is very low or when ...

Medically reviewed by Steffini Stalos, DO Hemophilia disease is a rare inherited bleeding disorder. People with this genetic ...